The novel JAK inhibitor AZD1480 blocks STAT3 and FGFR3 signaling, resulting in suppression of human myeloma cell growth and survival
A. Scuto, P. Krejci, L. Popplewell, J. Wu, Y. Wang, M. Kujawski, C. Kowolik, H. Xin, L. Chen, Y. Wang, L. Kretzner, H. Yu, W. R. Wilcox, Y. Yen, S. Forman, R. Jove
研究成果: 雜誌貢獻 › 文章 › 同行評審
102
引文
斯高帕斯（Scopus）